# Loss of hormone receptor expression in breast tissue following pre‐surgical therapy with an SERD

**Authors:** Francesco de Napoli, Bethania Fernandes, Silvia Uccella, Margherita D'Arezzo, Martina Iuzzolino, Luca Di Tommaso

PMC · DOI: 10.1111/his.70028 · 2025-10-31

## Full-text entities

- **Genes:** EGFR (epidermal growth factor receptor) [NCBI Gene 1956] {aka ERBB, ERBB1, ERRP, HER1, NISBD2, NNCIS}, ERBB2 (erb-b2 receptor tyrosine kinase 2) [NCBI Gene 2064] {aka CD340, HER-2, HER-2/neu, HER2, MLN 19, MLN-19}, NR4A1 (nuclear receptor subfamily 4 group A member 1) [NCBI Gene 3164] {aka GFRP1, HMR, N10, NAK-1, NGFIB, NP10}, PGR (progesterone receptor) [NCBI Gene 5241] {aka NR3C3, PR}, EREG (epiregulin) [NCBI Gene 2069] {aka EPR, ER, Ep}
- **Diseases:** breast carcinoma (MESH:D001943), SERDs (MESH:D055959), cancer (MESH:D009369), breast carcinogenesis (MESH:D061325)
- **Chemicals:** EE (MESH:D004997), fulvestrant (MESH:D000077267), SERD (-)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Figures

2 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12975673/full.md

---
Source: https://tomesphere.com/paper/PMC12975673